- KeyBanc’s Michael Leshock set a $135 price target on RKLB stock with an Overweight rating, implying ~29% upside from current levels.
- Q1 2026 revenue hit $200.3M — up 63% year-over-year — with a $2.2B backlog growing more than 100% annually.
- Insiders sold RKLB stock 130 times in six months with zero purchases; the SVP & General Counsel alone liquidated 25% of his position on June 18.
130 Insider Sales / 0 Buys (6 months)
The Bull Case for RKLB Stock: $135 Target, 88 Launches, and a Defense Pipeline
KeyBanc analyst Michael Leshock — ranked in the top 4% of Wall Street analysts by TipRanks — assigned RKLB stock an Overweight rating and a $135 price target on June 15, 2026. His thesis rests on three pillars: supply-constrained launch capacity, accelerating NASA and national security spending, and Rocket Lab’s optionality to build its own satellite constellation.
The numbers back the first two. Q1 2026 revenue came in at $200.3M, beating the Street by $10.8M and up 63% year-over-year. Backlog closed the quarter at $2.2B — more than doubling in twelve months. Recent contract wins are not vague pipeline talk: a $30M deal with Anduril Industries for hypersonic test flights using the HASTE suborbital vehicle, and a $90M US Space Force contract to deploy two geostationary satellites carrying the Heimdall space domain awareness payload.
Leshock is not the lone voice here. Of 13 analysts covering RKLB stock, 10 rate it Buy and 3 rate it Hold. The average price target across that group is $108.70. Deutsche Bank’s Edison Yu set $120. TD Cowen’s Gautam Khanna set $120. Needham’s Ryan Koontz set $120. Leshock’s $135 sits at the top of the range; KGI Securities and Stifel are at $105 — closer to the median of $105.
The SpaceX IPO last week at a trillion-dollar-plus valuation has reset what institutional investors will pay for space infrastructure. Leshock argues that dynamic benefits well-capitalized players like Rocket Lab, which already has 88 Electron launches and 260+ satellite deployments on its record. The Electron’s small-payload niche — under 300 kilograms to LEO — remains structurally differentiated from SpaceX’s bulk-launch economics.
What the Insider Data Actually Says About RKLB Stock
The bull thesis deserves a counterweight. On June 18 — the same day KeyBanc’s call was widely circulated — Arjun Kampani, RKLB’s SVP and General Counsel, sold 88,000 shares for an estimated $9.5M. That represented 25% of his entire position in that share class. He still holds 264,705 shares, so this is not a full exit — but the size and timing are notable.
Zoom out and the picture sharpens. Over the past six months, RKLB insiders executed 130 open-market sales and zero purchases. CFO Adam Spice led the group with 1,491,153 shares sold for an estimated $116.4M. COO Frank Klein sold 262,500 shares for ~$24.8M. CEO Peter Beck sold 18,857 shares for ~$1.3M. None of these executives purchased a single share on the open market during that window.
Institutional flows are split. Capital World Investors cut its RKLB stock position by 55.3% in Q1 2026 — roughly 8.96M shares worth an estimated $575M. VK Services exited entirely in Q4 2025. On the other side, Capital International Investors built a new position of 6.7M shares, Baillie Gifford added 5.73M shares, and Vanguard added 5.61M. Net institutional interest is not negative, but the rotation signal — major holders cashing out while new money steps in — warrants attention at a stock up 296% over the prior twelve months.
RKLB is still operating at a GAAP net loss. Q1 EPS came in at -$0.07, a penny better than forecast, but negative. The Neutron medium-lift rocket — the asset Leshock’s long-term model arguably depends on — remains under development with no confirmed commercial launch date.
RKLB stock carries a credible top-of-range price target from a well-ranked analyst, a backlog that doubled in a year, and two recent government contracts totaling $120M. The $135 target implies 29% upside from Leshock’s publication date; the consensus average at $108.70 implies closer to 4%. The gap between the top target and the consensus mean is the market’s embedded skepticism about execution — specifically whether the Neutron rocket transitions from development asset to revenue generator on any near-term schedule. Until Neutron launches commercially, Rocket Lab’s growth ceiling is capped by Electron’s small-payload economics. Meanwhile, 130 insider sales against zero purchases in six months is not a smoking gun — much of this is routine compensation liquidation — but it does establish that no insider is paying current market prices to add exposure.
Neutron medium-lift rocket: first announced commercial launch date and any schedule slip disclosures. That single data point will determine whether Leshock’s $135 target or the $105 median is the more defensible number.
Methodology: This brief uses TickerRead’s AI-assisted source-checking workflow and is built from public, source-linked market information. Methodology | Editorial Policy
Disclaimer: This post is for informational purposes only and does not constitute investment advice. All investment decisions and their outcomes are solely the responsibility of the reader.
Sources: Foreign Policy Journal, The Globe and Mail